SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay
NCT02730468 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 350
Last updated 2017-10-27
Summary
The purpose of this study is to evaluate the performance of the Karius Infectious Diseases Plasma Sequencing Assay in patients who present to the emergency room with sepsis.
Conditions
Sponsors & Collaborators
- collaborator OTHER
-
Karius, Inc.
lead INDUSTRY
Principal Investigators
-
Samuel Yang, MD · Stanford University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2017-09-30
- Completion
- 2017-10-31
Countries
- United States
Study Locations
More Related Trials
-
NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification
NCT06141395 ·Status: COMPLETED
-
Near Patient Molecular Testing in Sepsis
NCT05469048 ·Status: COMPLETED
-
Next-Generation Sequencing Diagnostics of Bacteremia in Sepsis
NCT03356249 ·Status: COMPLETED
-
Sepsis: From Syndrome to Personalized Care
NCT04203979 ·Status: RECRUITING
-
Impact of COVID-19 on the Incidence, Characteristics, Management and Outcome of Sepsis
NCT04698382 ·Status: WITHDRAWN
-
The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis
NCT03314831 ·Status: COMPLETED
-
Droplet Digital PCR Combines With Transcriptome Analysis in Early Warning of Sepsis in the Emergency Department
NCT06028178 ·Status: NOT_YET_RECRUITING
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
The INFUSE Trial - Intervening With Platelet Transfusions in Sepsis
NCT03090919 ·Status: WITHDRAWN ·Phase: NA
-
Procurement of Human Specimens for the Evaluation of Early Markers of Sepsis
NCT01746407 ·Status: COMPLETED
-
Comparison of Sepsis Prediction Algorithms
NCT05943938 ·Status: NOT_YET_RECRUITING
-
Defining Circulating Micro-RNA Biomarkers for the Early Diagnosis and Prognosis of Sepsis
NCT02544490 ·Status: COMPLETED
-
Molecular Diagnosis and Risk Stratification of Sepsis in India
NCT03727243 ·Status: UNKNOWN
-
Effect of APC and Epo on the Inflammatory Response During Sepsis
NCT00229034 ·Status: COMPLETED
-
Molecular Diagnosis and Risk Stratification of Sepsis
NCT01905033 ·Status: UNKNOWN
-
Early Identification of SEPsis SIGNs in Emergency Department
NCT04261621 ·Status: COMPLETED
-
The Value of Full-targeted Pathogen Capture Metagenomics Next Generation Sequencing in Etiological Diagnosis of Sepsis
NCT05540808 ·Status: UNKNOWN
-
Early PREdiction of Severe Sepsis I (ExPRES-Sepsis I) Study
NCT02188992 ·Status: COMPLETED
-
The Ward Study for SeptiCyte® Lab to Distinguish Between Infection-positive and Infection-negative SIRS
NCT02704871 ·Status: TERMINATED
-
The Ohio State University Sepsis Registry
NCT00837421 ·Status: TERMINATED
-
Correlating MicroRNA Changes With Sepsis Outcomes
NCT03929159 ·Status: ACTIVE_NOT_RECRUITING
-
Establishment of Early Diagnosis and Monitoring Model for Sepsis Patients
NCT04974411 ·Status: UNKNOWN
-
A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis
NCT00034476 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Days Alive and Out of Hospital for Patients With Sepsis
NCT04567433 ·Status: COMPLETED
-
Clearance of Antibacterial Agents During Hemoperfusion in Patients With Sepsis
NCT06602245 ·Status: COMPLETED